Dr. Fiore is a pharmaceutical / biotechnology executive and entrepreneur. He is the Founder of two life science consultancies, Fiore Healthcare Advisors (FHA) and SSI Strategy (SSI). He currently splits time between the two organizations and is the Chief Executive Officer at FHA and Chief Medical Officer at SSI.
Dr. Fiore is a recognized expert in clinical research and pharmacovigilance (PV) and has particular expertise in designing PV Systems, structuring programs to ensure appropriate medical oversight within clinical trials, and in participating in safety advisory committees. He has overseen pharmacovigilance and clinical research for more than 10 therapy areas and has experience in the US, Europe, Asia Pacific, and Latin America.
Prior to founding FHA, Dr. Fiore was the Chief Medical Officer of a global biotechnology company focused on hospital products for critically ill patients. The company had several marketed products as well as a rich pipeline and a high degree of business development activity. Dr. Fiore was responsible for Pharmacovigilance, Medical Affairs, Regulatory Affairs standards and platforms as well as Good Clinical Practices Quality. He was co-Chairperson of the Safety and Medical Policy Committee.
Before taking this role, he founded a Pharmacovigilance and Medical Affairs consultancy called SSI Strategy. SSI combines business consulting experience and discipline with pharmaceutical experience and domain expertise. Prior to SSI, Dr. Fiore spent time in roles of increasing responsibility in PV, including Regional Head of PV and Global Head of PV. He worked at companies such as Merck, Schering-Plough, and Abbott Laboratories. He also completed two business development deals and was Head of Alliance Management for two products.
Dr. Fiore was valedictorian at New York Medical College and trained in Internal Medicine at Harvard Medical School's Brigham and Women’s Hospital and then underwent further clinical training in Pulmonary and Critical Care Medicine in the Harvard Pulmonary and Critical Care fellowship program. From Harvard he joined McKinsey & Company where he worked on projects in a variety of industries including pharmaceuticals.
Dr. Fiore was a member of the CIOMS IX working group on Risk Minimization and has served on several safety advisory committees, including in the role of Chairperson. He has also served on the board of Dubset Media Holdings and is a Scientific Advisory Board member for Adverse Events, Inc. He also serves on the Editorial Advisory Board of Clinical Leader, an online journal aimed at providing solutions for the Pharmaceutical Industry.